There are several topics that my elderly patients discuss at every appointment, interaction, or social event. But on a broader scale, the topic of Cholesterol Medications in this population continues to be a somewhat more pressing issue in clinical circles…
Hey guys, look! A new paper on World Religions! I mean, Diets! The NEW STUDY results from Max Petersen’s group at University of Washington in St. Louis is probably, at least to some people, as surprising as something labeled “Washington”…
So I’m one of the authors of INCREASED LDL-C REDUCTION WITH EZETIMIBE IN KETOGENIC DIET-INDUCED HYPERCHOLESTEROLEMIA, which was recently accepted for publication in Lipids in Health and Disease. I haven’t historically been a fan of group projects; if I feel…
While we anxiously await the results from the HORIZON trial of Pelacarsen, a medication designed specifically to address the Lp(a) “Felons of the Lipid Neighborhood,” new publications LIKE THIS on the topic of Lp(a) continue to be released. And an…
I go on a lot of Podcasts, and I have to say that THIS EPISODE was actually one of my all-time favorites. Uncle Jimmy is a great host, and I hope you enjoy our discussion of how to NOT have…
August 1st was World RNA Day! A World Without RNA would be pretty lifeless, so I think it’s worthwhile to give you all a primer on this topic. (The people who got that joke probably don’t need to read this,…
In my ongoing effort to prove that I’m a TERRIBLE entrepreneur, but hopefully a pretty good friend if you need accessible Lipid Resources, below is a Helpful Handbook on Advanced Lipid Panels from the “Remixed 2nd Edition for the Clinician…And…
On a near-daily basis, people from across the country send me health-related Instagram reels, Podcasts, and articles asking for my opinion. And although I am continually humbled and honored to be a trusted resource on these matters, I admittedly sometimes…
“Got Milk?” -Ridiculous slogan from the 1990s accompanied by various celebrities featuring comically inappropriate white mustaches Prolactin is a fascinating hormone. If you possess the requisite anatomical machinery for milk production and are currently breastfeeding, then you’ll have “physiologic” hyperprolactinemia. …
Although we are still awaiting the full publication, THIS ANNOUNCEMENT was made today that ziltivekimab, an IL-6 inhibitor, went the way of Hades in the ZEUS trial. Unlike historic trials of other agents targeting inflammation (such as canakinumab and low-dose…
